Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Sanofi
Information provided by (Responsible Party):
William Sansum Diabetes Center
ClinicalTrials.gov Identifier:
NCT01662921
First received: August 7, 2012
Last updated: May 18, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2017
  Estimated Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)